Autoimmune bullous dermatoses;Autoimunitní bulózní dermatózy

Cesko-Slovenska Dermatologie

Volumn 81, Issue 4, 2006, Pages 188-197

  Cetkovska P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autoimmune bullous diseases; Dermatitis herpetiformis; Epidermolysis bullosa acquisita; Linear IgA dermatosis; Pemphigoid; Pemphigus

Indexed keywords

AUTOIMMUNE SKIN DISEASE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; DESMOSOME; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; MORBIDITY; MORTALITY; REVIEW;

EID: 33748513277     PISSN: 00090514     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. AHMED, AR., DAHL, MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol, 2003, 139, p. 1051-1059.
2. ANHALT, GJ., KIM, S., STANLEY, JR., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med, 1990, 323, p. 1729-1735.
3. BOLOGNIA, JL., JORIZZO, JL., RAPINI, RP. Dermatology. I.vyd. Edinburg: Elsevier Science Ltd, 2003, 2460 p.
4. BRENNER, S., BIALY-GOLAN, A., RUOCCO, V. Drug-induced pemphigus. Clin Dermatol, 1998, 16, p. 393-397.
5. CALLEN, JP., JORIZZO, LJ., BOLOGNIA, JL., et al. Dermatological signs of internal disease. 3. vyd. Philadelphia: Elsevier Science Ltd., 2003, 374 p.
6. CETKOVSKÁ, P. Kožní autoimunitní nemoci indukované léčbou. Čes-slov Derm, 2005, 80 (6), p. 322-325.
7. CETKOVSKÁ, P., PIZINGER, K., RESL, V. Mykofenolát mofetil v léčbě vybraných kožních nemocí. Čes-slov Derm, 2005, 80 (1), p. 11-14.
8. CETKOVSKÁ, P., PIZINGER, K. Childhood pemphigus associated with montelukast administration. Clin Exp Dermatol, 2003, 28(3), p. 328-329.
9. CETKOVSKÁ, P., PIZINGER, K., SKÁLOVÁ, A. Klinický případ: Svědivé puchýř e na končetinách a na trupu. Čes-slov Derm, 2001, 76 (4), p. 215-216.
10. DARLING, MR., DALEY, T. Blistering mucocutaneous diseases of the oral mucosa. A review: pemphigus vulgaris. J Can Dent Assoc, 2006, 72, p. 63-66.
11. DIETERICH, W., LAAG, E., BRUCKNER-TUDERMAN, L., et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol, 1999, 113, p. 133-136.
12. th ed. New York: McGraw-Hill, Inc., 2003, 2594 p.
13. HALE, EK., BYSTRYN, JC. Laryngeal and nasal involvement in pemphigus vulgaris. J Am Acad Dermatol, 2001, 44, p. 609-611.
14. HASHIMOTO, T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res, 2003, 295, S2-S11.
15. HERTL, M.: Autoimmune diseases of the skin. Wien: Springer Verlag, 2001, 373 p.
16. HERVONEN, K., VORNANEN, M., KAUTIAINEN, H., et al. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol, 2005, 152, p. 82-86.
17. HONOMICHLOVÁ, P., PIZINGER, K., CETKOVSKÁ, P. Paraneoplastický pemfigus. Čes-slov Derm, 2004, 79 (5), p. 173-175.
18. JEDLIČKOVÁ, H., SEMRÁDOVÁ, V., RAČOVSKÁ, J. Juvenilní pemfigus se závaž ným průběhem. Čes-slov Derm, 2000, 75 (5), p. 233-237.
19. JEDLIČKOVÁ, H. Dermoepidermální junkce a cílové antigeny u bulózního pemfigoidu. Čes-slov Derm, 2000, 75 (2), p. 80-84.
20. JEDLIČKOVÁ, H. Jizvící pemfigoid - klinicko-patologický rozbor 6 případů. Čes-slov Derm, 2000, 75 (3), p. 104-109.
21. MASCARO Jr, JM., ZILLIKENS, D., GIUDICE, GJ., et al. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kD dermal Ag. The first case report from the United States. J Am Acad Dermatol, 2000, 42, p. 309-315.
22. METRY, DW., HEBERT, AA., JORDON, RE. Nonendemic pemphigus foliaceus in children. J Am Acad Dermatol, 2002, 46, p. 419-422.
23. MIMOUNI, D., ANHALT, GJ., CUMMINS DL., et al. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol, 2003, 139, p. 739-742.
24. MUTASIM, DF. Management of autoimmune bullous diseases: Pharmacology and therapeutics. J Am Acad Dermatol, 2004, 51, p. 859-877.
25. MUTASIM, DF., ADAMS, BB. Immunofluorescence in dermatology. J Am Acad Dermatol, 2001, 45, p. 803-822.
26. POWELL, AM., ALBERT, S., AL FARES, S., et al. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol, 2003, 149, p. 138-145.
27. PREISZ, K., HORVÁTH, A., SÁRDY, M., et al. Exacerbation of paraneoplastic pemphigus by cyclophosphamide treatment: detection of novel autoantigens and bronchial autoantibodies. Br J Dermatol, 2004, 150, p. 1018-1024.
28. RUOCO, E., BARONI, A., WOLF, R., et al. Life threatening bullous dermatoses: Pemphigus vulgaris. Clin Dermatol, 2005, 23, p. 223-226.
29. ROBINSON, ND., HASHIMOTO, T., AMAGAY, M., et al. The new pemphigus variants. J Am Acad Dermatol, 1999, 40, p. 649-671.
30. SALAVEC, M., NOŽIČKA, Z., ROZSÍVALOVÁ, V., et al. The immunofluorescence evaluation of some subepidermal bullous diseases by use of NaCl-split skin. Sb Ved Pr LFUK Hradec Králové, 1994, 37, p. 67-71.
31. SARDY, M., KARPATI, S., MERKL, B., et al. Epidermal transglutaminase is the autoantigen of dermatitis herpetiformis. J Exp Med, 2002, p. 747-757.
32. TURCHIN, I., BARANKIN, B. Dermatitis herpetiformis and gluten-free diet. Dermatol Online J, 2005, vol. 11, No.1.
33. YANCEY, KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest, 2005, 115 (4), p. 825-828.
34. YANCEY, KB., EGAN, CA. Pemphigoid: clinical, histologic, immunopathologic and therapeutic considerations. JAMA, 2000, 284, p. 350-356.
35. YOSHIDA, K., TAKAE, Y., SAITO, H., et al. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus. J Am Acad Dermatol, 2005, 52, p. 839-845.